Literature DB >> 31386594

(Inverse) Agonists of Retinoic Acid-Related Orphan Receptor γ: Regulation of Immune Responses, Inflammation, and Autoimmune Disease.

Anton M Jetten1, Donald N Cook2.   

Abstract

Retinoic acid-related orphan receptor γt (RORγt) functions as a ligand-dependent transcription factor that regulates multiple proinflammatory genes and plays a critical role in several inflammatory and autoimmune diseases. Various endogenous and synthetic RORγ (inverse) agonists have been identified that regulate RORγ transcriptional activity, including many cholesterol intermediates and oxysterols. Changes in cholesterol biosynthesis and metabolism can therefore have a significant impact on the generation of oxysterol RORγ ligands and, consequently, can control RORγt activity and inflammation. These observations contribute to a growing literature that connects cholesterol metabolism to the regulation of immune responses and autoimmune disease. Loss of RORγ function in knockout mice and in mice treated with RORγ inverse agonists results in reduced production of proinflammatory cytokines, such as IL-17A/F, and increased resistance to autoimmune disease in several experimental rodent models. Thus, RORγt inverse agonists might provide an attractive therapeutic approach to treat a variety of autoimmune diseases.

Entities:  

Keywords:  (inverse) agonists; RORγ; Th17 cells; autoimmune disease; cholesterol biosynthesis; inflammation; retinoic acid–related orphan receptor

Mesh:

Substances:

Year:  2019        PMID: 31386594      PMCID: PMC6952538          DOI: 10.1146/annurev-pharmtox-010919-023711

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  149 in total

1.  Lineage relationship analysis of RORgammat+ innate lymphoid cells.

Authors:  Shinichiro Sawa; Marie Cherrier; Matthias Lochner; Naoko Satoh-Takayama; Hans Jörg Fehling; Francina Langa; James P Di Santo; Gérard Eberl
Journal:  Science       Date:  2010-09-23       Impact factor: 47.728

2.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

3.  Cutting edge: Ubiquitin-specific protease 4 promotes Th17 cell function under inflammation by deubiquitinating and stabilizing RORγt.

Authors:  Jing Yang; Peng Xu; Lei Han; Zhixiang Guo; Xiuwen Wang; Zuojia Chen; Jia Nie; Shuying Yin; Miranda Piccioni; Andy Tsun; Ling Lv; Shenglin Ge; Bin Li
Journal:  J Immunol       Date:  2015-03-27       Impact factor: 5.422

4.  Interleukin-12 and -23 Control Plasticity of CD127(+) Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria.

Authors:  Jochem H Bernink; Lisette Krabbendam; Kristine Germar; Esther de Jong; Konrad Gronke; Michael Kofoed-Nielsen; J Marius Munneke; Mette D Hazenberg; Julien Villaudy; Christianne J Buskens; Willem A Bemelman; Andreas Diefenbach; Bianca Blom; Hergen Spits
Journal:  Immunity       Date:  2015-07-14       Impact factor: 31.745

5.  High incidence of T-cell lymphomas in mice deficient in the retinoid-related orphan receptor RORgamma.

Authors:  Eiichiro Ueda; Shogo Kurebayashi; Morito Sakaue; Michael Backlund; Beverly Koller; Anton M Jetten
Journal:  Cancer Res       Date:  2002-02-01       Impact factor: 12.701

Review 6.  Th17 cells: from precursors to players in inflammation and infection.

Authors:  Amit Awasthi; Vijay K Kuchroo
Journal:  Int Immunol       Date:  2009-03-04       Impact factor: 4.823

7.  Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo.

Authors:  Jill Skepner; Radha Ramesh; Mark Trocha; Darby Schmidt; Erkan Baloglu; Mercedes Lobera; Thaddeus Carlson; Jonathan Hill; Lisa A Orband-Miller; Ashley Barnes; Mohamed Boudjelal; Mark Sundrud; Shomir Ghosh; Jianfei Yang
Journal:  J Immunol       Date:  2014-02-10       Impact factor: 5.422

8.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

Authors:  Marc Veldhoen; Richard J Hocking; Christopher J Atkins; Richard M Locksley; Brigitta Stockinger
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

9.  A validated regulatory network for Th17 cell specification.

Authors:  Maria Ciofani; Aviv Madar; Carolina Galan; Maclean Sellars; Kieran Mace; Florencia Pauli; Ashish Agarwal; Wendy Huang; Christopher N Parkhurst; Michael Muratet; Kim M Newberry; Sarah Meadows; Alex Greenfield; Yi Yang; Preti Jain; Francis K Kirigin; Carmen Birchmeier; Erwin F Wagner; Kenneth M Murphy; Richard M Myers; Richard Bonneau; Dan R Littman
Journal:  Cell       Date:  2012-09-25       Impact factor: 41.582

10.  RORgamma t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells.

Authors:  Y W He; M L Deftos; E W Ojala; M J Bevan
Journal:  Immunity       Date:  1998-12       Impact factor: 31.745

View more
  14 in total

1.  Discovery of BMS-986251: A Clinically Viable, Potent, and Selective RORγt Inverse Agonist.

Authors:  Robert J Cherney; Lyndon A M Cornelius; Anurag Srivastava; Carolyn A Weigelt; David Marcoux; James J-W Duan; Qing Shi; Douglas G Batt; Qingjie Liu; Shiuhang Yip; Dauh-Rurng Wu; Max Ruzanov; John Sack; Javed Khan; Jinhong Wang; Melissa Yarde; Mary Ellen Cvijic; Arvind Mathur; Sha Li; David Shuster; Purnima Khandelwal; Virna Borowski; Jenny Xie; Mary Obermeier; Aberra Fura; Kevin Stefanski; Georgia Cornelius; Joseph A Tino; John E Macor; Luisa Salter-Cid; Rex Denton; Qihong Zhao; Percy H Carter; T G Murali Dhar
Journal:  ACS Med Chem Lett       Date:  2020-03-31       Impact factor: 4.345

2.  Conformational Changes of RORγ During Response Element Recognition and Coregulator Engagement.

Authors:  Timothy S Strutzenberg; Yingmin Zhu; Scott J Novick; Ruben D Garcia-Ordonez; Christelle Doebelin; Yuanjun He; Mi Ra Chang; Theodore M Kamenecka; Dean P Edwards; Patrick R Griffin
Journal:  J Mol Biol       Date:  2021-09-20       Impact factor: 5.469

3.  Deregulation of Cholesterol Homeostasis by a Nuclear Hormone Receptor Crosstalk in Advanced Prostate Cancer.

Authors:  Nianxin Yang; Yatian Yang; Zenghong Huang; Hong-Wu Chen
Journal:  Cancers (Basel)       Date:  2022-06-24       Impact factor: 6.575

Review 4.  Decoding IL-23 Signaling Cascade for New Therapeutic Opportunities.

Authors:  Gloria Pastor-Fernández; Isabel R Mariblanca; María N Navarro
Journal:  Cells       Date:  2020-09-07       Impact factor: 6.600

5.  Targeting Feedforward Loops Formed by Nuclear Receptor RORγ and Kinase PBK in mCRPC with Hyperactive AR Signaling.

Authors:  Xiong Zhang; Zenghong Huang; Junjian Wang; Zhao Ma; Joy Yang; Eva Corey; Christopher P Evans; Ai-Ming Yu; Hong-Wu Chen
Journal:  Cancers (Basel)       Date:  2021-04-01       Impact factor: 6.639

Review 6.  ROR: Nuclear Receptor for Melatonin or Not?

Authors:  Haozhen Ma; Jun Kang; Wenguo Fan; Hongwen He; Fang Huang
Journal:  Molecules       Date:  2021-05-04       Impact factor: 4.411

7.  Reply to Jakovac and to Rocha et al.: Can vitamin D prevent or manage COVID-19 illness?

Authors:  Andrzej T Slominski; Radomir M Slominski; Paul A Goepfert; Tae-Kang Kim; Michael F Holick; Anton M Jetten; Chander Raman
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-08-01       Impact factor: 4.310

8.  Preclinical and clinical characterization of the RORγt inhibitor JNJ-61803534.

Authors:  Xiaohua Xue; Aimee De Leon-Tabaldo; Rosa Luna-Roman; Glenda Castro; Michael Albers; Freddy Schoetens; Samuel DePrimo; Damayanthi Devineni; Thomas Wilde; Steve Goldberg; Olaf Kinzel; Thomas Hoffmann; Anne M Fourie; Robin L Thurmond
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379

9.  Antifibrogenic Activities of CYP11A1-derived Vitamin D3-hydroxyderivatives Are Dependent on RORγ.

Authors:  Zorica Janjetovic; Arnold Postlethwaite; Hong Soon Kang; Tae-Kang Kim; Robert C Tuckey; David K Crossman; Shariq Qayyum; Anton M Jetten; Andrzej T Slominski
Journal:  Endocrinology       Date:  2021-01-01       Impact factor: 5.051

10.  COVID-19 and Vitamin D: A lesson from the skin.

Authors:  Radomir M Slominski; Joanna Stefan; Mohammad Athar; Michael F Holick; Anton M Jetten; Chander Raman; Andrzej T Slominski
Journal:  Exp Dermatol       Date:  2020-09-09       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.